Premium
Care in the time of coronavirus: Ethical considerations in head and neck oncology
Author(s) -
Gordin Eli A.,
Day Andrew,
Stankova Lenka,
Heitman Elizabeth,
Sadler John
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26272
Subject(s) - head and neck cancer , medicine , health care , pandemic , perspective (graphical) , scarcity , covid-19 , welfare , nursing , family medicine , cancer , disease , political science , infectious disease (medical specialty) , artificial intelligence , computer science , law , economics , microeconomics
As COVID‐19 continues to challenge the practice of head and neck oncology, clinicians are forced to make new decisions in the setting of the pandemic that impact the safety of their patients, their institutions, and themselves. The difficulty inherent in these decisions is compounded by potentially serious ramifications to the welfare of patients and health‐care staff, amid a scarcity of data on which to base informed choices. This paper explores the risks of COVID‐19 incurred while striving to uphold the standard of care in head and neck oncology. The ethical problems are assessed from the perspective of the patient with cancer, health‐care provider, and other patients within the health‐care system. While no single management algorithm for head and neck cancer can be universally implemented, a detailed examination of these issues is necessary to formulate ethically sound treatment strategies.